A01K 67/0275
Genetically modified vertebrates
Official title: Genetically modified vertebrates, e.g. transgenic
A01K67/0275 (Genetically modified vertebrates) appears on 3,245 US grants and 5,636 published applications in this corpus.
Search patents in A01K- Granted patents
- 3,245
- Published applications
- 5,636
- Assignees
- 1,767
- Inventors
- 8,904
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 8 | 0 |
| 1993 | 2 | 0 |
| 1994 | 8 | 0 |
| 1995 | 9 | 0 |
| 1996 | 39 | 0 |
| 1997 | 65 | 0 |
| 1998 | 98 | 0 |
| 1999 | 92 | 0 |
| 2000 | 88 | 0 |
| 2001 | 104 | 24 |
| 2002 | 77 | 241 |
| 2003 | 101 | 286 |
| 2004 | 74 | 243 |
| 2005 | 58 | 267 |
| 2006 | 103 | 284 |
| 2007 | 96 | 198 |
| 2008 | 90 | 209 |
| 2009 | 101 | 226 |
| 2010 | 113 | 238 |
| 2011 | 90 | 234 |
| 2012 | 104 | 177 |
| 2013 | 108 | 192 |
| 2014 | 105 | 226 |
| 2015 | 124 | 235 |
| 2016 | 126 | 231 |
| 2017 | 141 | 236 |
| 2018 | 139 | 220 |
| 2019 | 135 | 278 |
| 2020 | 144 | 244 |
| 2021 | 138 | 222 |
| 2022 | 120 | 222 |
| 2023 | 134 | 182 |
| 2024 | 110 | 216 |
| 2025 | 115 | 174 |
| 2026 | 80 | 131 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Method for producing genetically edited birds having resistance to avian influenza viruses22 Sep 2026US 12,742,180 B2Seoul National University R&Db Foundation
- Efficient non-meiotic allele introgression in livestock1 Sep 2026US 12,721,326 B2Tog Technologies, LLC
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
- Single-sex chicken with toxin-antitoxin system1 Oct 2026US 2026/0293865 A1New York University
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996